GANX vs IFF · $53.0M cap vs P/E 24, rev $3.86B
Gain Therapeutics Inc (GANX) versus International Flavors & Fragrances Inc (IFF) — a side-by-side from cached financials, not a winner call.
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
International Flavors & Fragrances Inc (IFF) is a specialty chemicals company listed on NYSE.
GANX does not have a complete income-statement cache yet.
Latest reported IFF revenue for 2026-06-30 was $3.86B. Net income was $219.0M. Revenue was up 40.8% from 2026-03-31 to 2026-06-30. IFF currently screens at market cap $19.42B and trailing P/E 23.5.
GANX currently screens at market cap $53.0M. IFF currently screens at market cap $19.42B and trailing P/E 23.5.
Not investment advice. Open the GANX and IFF stock pages for the full models.
Not investment advice.